Charles Moore,  —

Charles Moore is a syndicated columnist for several major Canadian print newspapers and the Science and Research Section editor for CF News Today.

Articles by Charles Moore

Researchers Find Sugar Agent Protects Cells Against CF Superbug Threat Pseudomonas Aeruginosa

A team of research scientists at the University of Freiburg (Albert-Ludwigs-Universität Freiburg) at Freiburg im Breisgau, Baden-Württemberg, Germany, the University of Geneva, and the University of Grenoble report that they have succeeded in preventing the hospital-acquired bacteria Pseudomonas aeruginosa, a pathogen particularly dangerous to persons with Cystic Fibrosis (CF), from…

AffloVest Portable Airway Clearance Device Enhances Treatment Mobility And Comfort For CF and COPD Patients

Austin-based International Biophysics Corporation’s marquee product, AffloVest, is a cutting-edge technology airway clearance vest that represents a major advance in treatment of respiratory diseases such as Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Disease (COPD), chronic bronchitis, and similar related ailments. This High Frequency Chest Wall Oscillation (HFCWO) vest that gives…

Laurent Pharmaceuticals Initiates Phase 1 Clinical Study Of “Orphan Drug” Fenretinide in Cystic Fibrosis

Montreal-based biotech startup Laurent Pharmaceuticals Inc. announced Wednesday that the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal has begun enrolling patients in an investigator-initiated clinical trial evaluating the safety, tolerability and pharmacokinetics of a novel oral formulation of Fenretinide in adult subjects with Cystic…

Your CF Community

Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.